Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Selskabsmeddelelse

ChromoGenics AB (publ): ChromoGenics communicates order data for the fourth quarter in 2023 and postpones publication of the year-end report for 2023.

ChromoGenics
Download udgivelse

ChromoGenics order intake for the fourth quarter 2023 amounted to 6,6 MSEK and the order book for the same period was 11,5 MSEK.

Due to unexpected administrative reasons, the Board of Directors of ChromoGenics has decided to postpone the publication of the year-end report for 2023 until 8[th] of March 2024. Previously communicated date for submission of the report was on the 20[th] of February 2024.

Full data on the fourth quarter 2023 will be published in the year-end report.

Contact:

Fredrik Fränding, CEO
Anne-Marie Gullman, CFO & Head of Investor Relations
Tel: +46 (0) 18 430 0430

E-mail: info@chromogenics.com

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.